![\"\"](\"https:\/\/biovegen.org\/wp-content\/uploads\/2020\/06\/Azul-Caracter\u00edsticas-generales.jpg\")
<\/figure>\n\n\n\n- ACTIVITY:<\/strong> Biotechnology to improve the therapeutic potential of various medicinal plants.<\/li>
- LOCATION: <\/strong>Barcelona.<\/li>
- CONSTITUTION DATE:<\/strong> 10\/2018.<\/li>
- CATEGORY: <\/strong>small agropharma\/plant biotechnology company.<\/li>
- CONTACT: <\/strong>(+34) 695 124 590.<\/li><\/ul>\n\n\n\n
<\/div>\n\n\n\n![\"\"](\"data:image\/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==\")
<\/figure>\n\n\n\n- NUMBER OF EMPLOYEES:<\/strong> 5.<\/li>
- INCOME: -<\/strong><\/li>
- GENERAL DESCRIPTION:<\/strong> Biotech Tricopharming Research SL<\/strong> is a biotechnology start-up founded in 2018 after several years of R&D. Our general mission is to create the know-how and technologies necessary to increase the therapeutic potential of different medicinal and aromatic plants (MAPs). The Biopharmaceutical agriculture<\/em> either Biopharming <\/em>It combines biotechnology and agriculture to produce valuable pharmacological products in plants but at a reduced cost. In our first product, Artennua\u00ae<\/strong>, we increase the production of various compounds of interest in the plant Artemisia annua<\/em>; a plant used to combat malaria, cancer, as well as other diseases in both humans and animals<\/li>
- BUSINESS LINES: <\/strong>Sale of Artennua\u00ae for nutraceutical, natural cosmetics and animal health sectors. License to use our technology TricoStimulant\u2122<\/strong> for different MAPs plants.<\/li>
- INFRASTRUCTURE: <\/strong>Headquarters in Barcelona. Operational, production and experimental headquarters in Tenerife.<\/li>
- DATA OF INTEREST: <\/strong>Although created in 2018, R&D was developed in-house Sequentia Biotech SL<\/em><\/strong><\/a> from 2015 to 2018.<\/li><\/ul>\n\n\n\n
<\/div>\n\n\n\n<\/figure>\n\n\n\nTECHNOLOGICAL SUPPLY\/DEMAND:<\/strong><\/p>\n\n\n\n
- We offer consultancy <\/strong>and customized R&D projects<\/strong> to companies or research centers to increase the therapeutic potential of different MAPs.<\/li>
- We develop biostimulants <\/strong>tailored.<\/li>
- We search collaborations <\/strong>with other companies and\/or research centers to new R&D projects<\/strong>.<\/li>
- We search collaborations <\/strong>with other companies and\/or research centers to study stability <\/strong>and new formats <\/strong>for different biostimulants.<\/li><\/ul>\n\n\n\n
<\/div>\n\n\n\n<\/figure>\n\n\n\nDEVELOPMENT PROJECTS<\/strong><\/p>\n\n\n\n
- Platform <\/strong>production of therapeutic molecules in plants. CDTI<\/em>.<\/li><\/ul>\n\n\n\n
COMPLETED PROJECTS<\/strong><\/p>\n\n\n\n
- Biotechnology for production <\/strong>of the molecule artemisinin <\/strong>in the trichomes of the plant Artemisia annua<\/em>. Validation <\/strong>of technology TricoStimulant\u2122<\/em> on field. MINECO-CDTI<\/em>.<\/li><\/ul>","protected":false},"excerpt":{"rendered":"
Biofactory plants\/industrial crops<\/p>","protected":false},"author":1,"featured_media":21288,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[14,293,2,437,277,279],"tags":[],"class_list":["post-762","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-socios","category-cataluna","category-empresas","category-plantas-biofactoria-cultivos-industriales","category-localizacion","category-sector"],"acf":[],"_links":{"self":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts\/762","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/comments?post=762"}],"version-history":[{"count":0,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/posts\/762\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/media\/21288"}],"wp:attachment":[{"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/media?parent=762"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/categories?post=762"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/biovegen.org\/en\/wp-json\/wp\/v2\/tags?post=762"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
- Biotechnology for production <\/strong>of the molecule artemisinin <\/strong>in the trichomes of the plant Artemisia annua<\/em>. Validation <\/strong>of technology TricoStimulant\u2122<\/em> on field. MINECO-CDTI<\/em>.<\/li><\/ul>","protected":false},"excerpt":{"rendered":"
- We develop biostimulants <\/strong>tailored.<\/li>
- INCOME: -<\/strong><\/li>
- LOCATION: <\/strong>Barcelona.<\/li>
![\"\"](\"https:\/\/biovegen.org\/wp-content\/uploads\/2020\/06\/Azul-Estructura-empresarial.jpg\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/biovegen.org\/wp-content\/uploads\/2020\/06\/Azul-Actividades-intereses-ID.jpg\")
<\/figure>\n\n\n\n![\"\"](\"https:\/\/biovegen.org\/wp-content\/uploads\/2020\/06\/Azul-Participaci\u00f3n-en-proyectos.jpg\")
<\/figure>\n\n\n\n